Thus, in addition to eliminating Ang II–induced CF proliferation and ECM synthesis, TRIM33 overexpression protects against Ang II–induced heart size, cardiac dysfunction and myocardial fibrosis in vivo. The gene discussed is AGT; the disease is cystic fibrosis.